Oragenics, Inc. (OGEN) stock surged +1.23%, trading at $0.29 on AMEX, up from the previous close of $0.28. The stock opened at $0.53, fluctuating between $0.25 and $0.63 in the recent session.
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement with Precigen, Inc. and ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.
Employees | 5 |
Beta | 0.48 |
Sales or Revenue | $37.65K |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Oragenics, Inc. (AMEX: OGEN) stock price is $0.29 in the last trading session. During the trading session, OGEN stock reached the peak price of $0.63 while $0.25 was the lowest point it dropped to. The percentage change in OGEN stock occurred in the recent session was 1.23% while the dollar amount for the price change in OGEN stock was $0.00.
The AMEX listed OGEN is part of Biotechnology industry that operates in the broader Healthcare sector. Oragenics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Michael O. Sullivan CPA
Consultant
Dr. Martin Handfield M.Sc., Ph.D.
Chief Scientific Officer
Ms. Kimberly M. Murphy
Pres, Chief Executive Officer, Sec., Treasurer & Director
Dr. Frederick W. Telling Ph.D.
Executive Chairman
OGEN's closing price is 13.64% higher than its 52-week low of $0.25 where as its distance from 52-week high of $4.00 is -92.9%.
Number of OGEN employees currently stands at 5.
Official Website of OGEN is: https://www.oragenics.com
OGEN could be contacted at phone 813 286 7900 and can also be accessed through its website. OGEN operates from 4902 Eisenhower Boulevard, Tampa, FL 33634, United States.
OGEN stock volume for the day was 242.03M shares. The average number of OGEN shares traded daily for last 3 months was 877.93K.
The market value of OGEN currently stands at $3.62M with its latest stock price at $0.29 and 12.57M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com